Ignite Creation Date:
2025-12-24 @ 6:35 PM
Ignite Modification Date:
2025-12-24 @ 6:35 PM
Study NCT ID:
NCT03777657
Status:
COMPLETED
Last Update Posted:
2025-02-14
First Post:
2018-11-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma
Sponsor:
BeiGene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-13
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-27
Completion Date Type:
ACTUAL
First Submit Date:
2018-11-09
First Submit QC Date:
None
Study First Post Date:
2018-12-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-01-24
Results First Submit QC Date:
None
Results First Post Date:
2025-02-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-02-07
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-01-24
Last Update Post Date:
2025-02-14
Last Update Post Date Type:
ACTUAL